Paper Review Records
All Paper Review Records
13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
155
days
A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations
AuthorsKarl Vivoda; Harvey Koh; Tamrat Befekadu Abebe; Sheridan Rodda; Chris Bain; Zanfina Ademi
Affiliations1. Health Economics and Policy Evaluation Research (HEPER) Group, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia; 2. School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; 3. Faculty of IT, Monash University, Clayton, Australia; 4. Faculty of Medicine, University of Prishtina, Prishtina, Kosovo; 5. School of Pharmacy, University of Eastern Finland, Kuopio, Finland
130
days
Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration
AuthorsEun-Young Bae; Jahyun Cho; Jooho Moon; Brendan Mulhern; Donna Rowen; Jakob Bue Bjorner; Min-Woo Jo
Affiliations1. College of Pharmacy, Gyeongsang National University, Jinju, South Korea; 2. Graduate School of Public Health, Seoul National University, Seoul, South Korea; 3. Department of Economics, Seoul National University, Seoul, South Korea; 4. Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, Australia; 5. Sheffield Centre for Health and Related Research (SCHARR), School of Medicine and Population Health, University of Sheffield, Sheffield, UK; 6. IQVIA, Research and Development Solutions, Copenhagen, Denmark; 7. Department of Public Health, University of Copenhagen, Copenhagen, Denmark; 8. National Centre for the Working Environment, Copenhagen, Denmark; 9. Department of preventive medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
216
days
Informing the Equitable Implementation of Hepatitis C Interventions: Cost-Effectiveness Modeling in Rural Populations of People Who Inject Drugs
AuthorsSheri A. Tubach; François M. Castonguay
Affiliations1. School of Public Health, University of Illinois Chicago, Chicago, USA; 2. Department of Health Management, Evaluation, and Policy, University of Montreal School of Public Health, Montreal, Canada
86
days
Cost-Utility Analysis of Calcitonin Gene-Related Peptide Monoclonal Antibodies for Patients with Episodic Migraine Headache in the USA
AuthorsAriel Weiming Dong; Mark Bounthavong
Affiliations1. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, USA
122
days
Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective
AuthorsKun Shi-van Wielink; Annegret Dahlmann-Noor; Jieyi Li; Thom W. L. de Milliano; Frederic Ernst; Francesco Croci; Yuvraj Sharma; Yogesh Punekar
Affiliations1. Santen Pharmaceutical SA, Amsterdam, Netherlands; 2. NIHR Moorfields Biomedical Research Centre, London, UK; 3. University College London, London, UK; 4. Moorfields Eye Hospital NHS Foundation Trust, London, UK; 5. Santen Pharmaceuticals SA, Geneva, Switzerland; 6. Santen Pharmaceuticals GmbH, Munich, Germany; 7. IQVIA, London, UK
130
days
Cost-Effectiveness and Budget-Impact Analysis of Semaglutide in Heart Failure with Preserved Ejection Fraction and Obesity in the German Health-Care System
AuthorsBent Estler; Hanna Fröhlich; Tobias Täger; Norbert Frey; Lutz Frankenstein
Affiliations1. Department of Cardiology, Angiology and Pulmology, University Hospital Heidelberg, Heidelberg, Germany
163
days
A Systematic Literature Review of Health Economic Modelling Approaches Used to Evaluate Treatment Resistant and Uncontrolled Hypertension: A Critical Appraisal and Considerations for the Design of Future Model Analyses
AuthorsMatthew Franklin; James Fotheringham; Rod S. Taylor; Philip A. Powell; Lise Retat; Jieling Chen; Juan Jose Garcia Sanchez; Amy Gamble; Patrice Carter
Affiliations1. Sheffield Centre for Health and Related Research (SCHARR), Division of Population Health, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK; 2. School of Health and Well Being, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK; 3. AstraZeneca, Barcelona, Spain; 4. AstraZeneca R&D Pharmaceuticals, Gaithersburg, USA; 5. Health Economics & Outcomes Research Ltd, Cardiff, UK
136
days
Real-World Economic Burden Associated with Progressive Pulmonary Fibrosis in the US: An Administrative Claims Database Analysis
AuthorsJoseph Yang; Bonnie H. Bui; Tim Bancroft; Andrea Steffens; Rebecca Fee; Bijan J. Borah
Affiliations1. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, USA; 2. Optum, Inc., Eden Prairie, USA; 3. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, USA
143
days
Identifying and Comparing Intervention Cost Components in Remote Patient Monitoring: A Scoping Review
AuthorsAnna L. Heilig; Wilbert B. van den Hout; M. Elske van den Akker-van Marle
Affiliations1. Department of Biomedical Data Science, Leiden University Medical Center, Leiden, The Netherlands
61
days
Using Proportional and Absolute Shortfall in Reimbursement Decision-Making in the Netherlands: Implications for Oncology Drugs for Older Patients
AuthorsVivian Reckers-Droog; Steef Redeker; Jan Busschbach; Sylvia Vijgen; Angèl Link; Lonneke Timmers
Affiliations1. Erasmus School of Health Policy and Management, Section Health Economics, Erasmus University Rotterdam, Rotterdam, The Netherlands; 2. National Health Care Institute, Diemen, The Netherlands; 3. Department of Psychiatry, Section Medical Psychology and Psychotherapy, Erasmus University Medical Center, Rotterdam, The Netherlands
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days